117 related articles for article (PubMed ID: 36780791)
1. Treatment planning of carbon ion radiotherapy for prostate cancer based on cellular experiments with PC3 human prostate cancer cells.
Wakisaka Y; Minami K; Okada N; Tsubouchi T; Hamatani N; Yagi M; Takashina M; Kanai T
Phys Med; 2023 Mar; 107():102537. PubMed ID: 36780791
[TBL] [Abstract][Full Text] [Related]
2. Treatment planning of intensity modulated composite particle therapy with dose and linear energy transfer optimization.
Inaniwa T; Kanematsu N; Noda K; Kamada T
Phys Med Biol; 2017 Jun; 62(12):5180-5197. PubMed ID: 28333688
[TBL] [Abstract][Full Text] [Related]
3. [Dose and Radiation Quality Optimized Heavy-Ion Radiotherapy].
Inaniwa T
Igaku Butsuri; 2020; 40(1):23-27. PubMed ID: 32238679
[TBL] [Abstract][Full Text] [Related]
4. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model.
Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q
Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity study of the microdosimetric kinetic model parameters for carbon ion radiotherapy.
Dahle TJ; Magro G; Ytre-Hauge KS; Stokkevåg CH; Choi K; Mairani A
Phys Med Biol; 2018 Nov; 63(22):225016. PubMed ID: 30418940
[TBL] [Abstract][Full Text] [Related]
6. Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions.
Zeng C; Giantsoudi D; Grassberger C; Goldberg S; Niemierko A; Paganetti H; Efstathiou JA; Trofimov A
Med Phys; 2013 May; 40(5):051708. PubMed ID: 23635256
[TBL] [Abstract][Full Text] [Related]
7. Calculating dose-averaged linear energy transfer in an analytical treatment planning system for carbon-ion radiotherapy.
Wang W; Li P; Shahnazi K; Wu X; Zhao J
J Appl Clin Med Phys; 2023 Feb; 24(2):e13866. PubMed ID: 36527366
[TBL] [Abstract][Full Text] [Related]
8. Spot-scanning hadron arc (SHArc) therapy: A proof of concept using single- and multi-ion strategies with helium, carbon, oxygen, and neon ions.
Mein S; Kopp B; Tessonnier T; Liermann J; Abdollahi A; Debus J; Haberer T; Mairani A
Med Phys; 2022 Sep; 49(9):6082-6097. PubMed ID: 35717613
[TBL] [Abstract][Full Text] [Related]
9. Carbon ion irradiation of the human prostate cancer cell line PC3: a whole genome microarray study.
Suetens A; Moreels M; Quintens R; Chiriotti S; Tabury K; Michaux A; Grégoire V; Baatout S
Int J Oncol; 2014 Apr; 44(4):1056-72. PubMed ID: 24504141
[TBL] [Abstract][Full Text] [Related]
10. Dose Distribution Degradation of Carbon-ion Radiotherapy Caused by Tumor Cell-specific Relative Biological Effectiveness of Osteosarcoma: A Simulation Study Using
Shiba S; Kawashima M; Okamoto M; Ohno T
Anticancer Res; 2023 Nov; 43(11):4873-4878. PubMed ID: 37909964
[TBL] [Abstract][Full Text] [Related]
11. Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan.
Inaniwa T; Kanematsu N; Matsufuji N; Kanai T; Shirai T; Noda K; Tsuji H; Kamada T; Tsujii H
Phys Med Biol; 2015 Apr; 60(8):3271-86. PubMed ID: 25826534
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the dose variation for prostate heavy charged particle therapy using four-dimensional computed tomography.
Kumagai M; Okada T; Mori S; Kandatsu S; Tsuji H
J Radiat Res; 2013 Mar; 54(2):357-66. PubMed ID: 23263729
[TBL] [Abstract][Full Text] [Related]
13. Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel.
Rucinski A; Brons S; Richter D; Habl G; Debus J; Bert C; Haberer T; Jäkel O
Radiat Oncol; 2015 Feb; 10():56. PubMed ID: 25886457
[TBL] [Abstract][Full Text] [Related]
14. Carbon ion radiotherapy using fiducial markers for prostate cancer in Osaka HIMAK: Treatment planning.
Tsubouchi T; Hamatani N; Takashina M; Wakisaka Y; Ogawa A; Yagi M; Terasawa A; Shimazaki K; Chatani M; Mizoe J; Kanai T
J Appl Clin Med Phys; 2021 Sep; 22(9):242-251. PubMed ID: 34339590
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison.
De Meerleer GO; Vakaet LA; De Gersem WR; De Wagter C; De Naeyer B; De Neve W
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):639-48. PubMed ID: 10837946
[TBL] [Abstract][Full Text] [Related]
16. Interfractional robustness of scanning carbon ion radiotherapy for prostate cancer: An analysis based on dose distribution from daily in-room CT images.
Tsuchida K; Minohara S; Kusano Y; Kano K; Anno W; Takakusagi Y; Mizoguchi N; Serizawa I; Yoshida D; Imura K; Takayama Y; Kamada T; Katoh H; Ohno T
J Appl Clin Med Phys; 2021 Jun; 22(6):130-138. PubMed ID: 34046997
[TBL] [Abstract][Full Text] [Related]
17. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer.
Martinez AA; Yan D; Lockman D; Brabbins D; Kota K; Sharpe M; Jaffray DA; Vicini F; Wong J
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1226-34. PubMed ID: 11483333
[TBL] [Abstract][Full Text] [Related]
18. The comparison of radiotherapy techniques for treatment of the prostate cancer: the three-field vs. the four-field.
Milecki P; Piotrowski T; Dymnicka M
Neoplasma; 2004; 51(1):64-9. PubMed ID: 15004663
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.
Rana S; Cheng C; Zheng Y; Hsi W; Zeidan O; Schreuder N; Vargas C; Larson G
J Appl Clin Med Phys; 2014 May; 15(3):4611. PubMed ID: 24892333
[TBL] [Abstract][Full Text] [Related]
20. Voxel based evaluation of sequential radiotherapy treatment plans with different dose fractionation schemes.
Singh G; Kamal R; Thaper D; Oinam AS; Handa B; Kumar V; Kumar N
Br J Radiol; 2020 Aug; 93(1112):20200197. PubMed ID: 32614607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
